Pete Pharma and Atrium24 Announced a GPO Partnership
Edited by Debra John — March 24, 2026 — Tech
This article was written with the assistance of AI.
References: 3dprint
Pete Pharma, a Phoenix R&D startup, launched a 3D-printed pharmaceutical offering for independent pharmacies, featuring the M3DIMAKER platform distributed via a new group purchase organization (GPO) channel. The deal positions Pete Pharma as the primary supplier of 3D printing infrastructure and related materials to Atrium24’s member network.
The agreement builds on Pete Pharma’s September 2025 distribution tie-up with FABRX, maker of the M3DIMAKER 3D printer, and integrates printing hardware, formulation support and supply agreements into Atrium24’s Dotti platform. Atrium24 will negotiate pricing and onboarding for pharmacies, enabling bundled procurement and service access across the nationwide GPO.
For consumers, the move could expand local compounding capabilities by bringing on-demand, custom-dosage manufacturing to neighborhood pharmacies, improving convenience and personalization. By lowering adoption barriers for independents, the partnership signals a practical commercialization path for additive manufacturing in pharmacy compounding.
Image Credit: Gorodenkoff / Shutterstock
The agreement builds on Pete Pharma’s September 2025 distribution tie-up with FABRX, maker of the M3DIMAKER 3D printer, and integrates printing hardware, formulation support and supply agreements into Atrium24’s Dotti platform. Atrium24 will negotiate pricing and onboarding for pharmacies, enabling bundled procurement and service access across the nationwide GPO.
For consumers, the move could expand local compounding capabilities by bringing on-demand, custom-dosage manufacturing to neighborhood pharmacies, improving convenience and personalization. By lowering adoption barriers for independents, the partnership signals a practical commercialization path for additive manufacturing in pharmacy compounding.
Image Credit: Gorodenkoff / Shutterstock
Custom-dose meds at local pharmacies
Informs near-term decisions to use a compounding pharmacy, request custom dosing, or switch where you fill prescriptions.
1 / 3
When was the last time you used a compounding pharmacy?
2 / 3
Next time you fill a prescription, how likely to request a custom dose?
3 / 3
Which would you be more likely to choose at pickup?
Trend Themes
-
Localized On-demand Compounding — Neighborhood pharmacies are positioned to provide personalized, on-site manufacturing of customized dosages that reduce reliance on centralized compounding facilities.
-
Gpo-led Technology Adoption — Group purchasing organizations are enabling rapid diffusion of advanced manufacturing platforms by bundling procurement, training and service agreements for smaller healthcare providers.
-
Integrated Hardware-software Pharma Platforms — Converged offerings that pair 3D printers with formulation libraries and cloud-based onboarding are creating turnkey solutions that lower technical barriers to entry.
Industry Implications
-
Independent Community Pharmacies — Local pharmacies may transform into micro-manufacturers offering same-day, patient-specific medications that change the retail pharmacy value proposition.
-
Medical Device and Printer Manufacturers — Companies producing 3D printing hardware and consumables could shift from one-time equipment sales to recurring-revenue models tied to materials, software licenses and service contracts.
-
Pharmaceutical Supply Chain and Distribution — Distributors and GPOs could evolve into technology integrators that coordinate supply, quality assurance and regulatory compliance for distributed drug manufacturing networks.
8.3
Score
Popularity
Activity
Freshness
